Related Experiment Video
Updated: Jun 5, 2026

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
Citicoline in vascular cognitive impairment and vascular dementia after stroke
Jose Alvarez-Sabín1, Gustavo C Román
1Neurovascular Unit, Department of Neurology, Universitat Autónoma de Barcelona, Hospital Vall d'Hebron, Barcelona, Spain.
Insights
Citicoline may prevent cognitive decline following a stroke. This study found it improved attention and executive function in patients with first-ever ischemic stroke, offering a promising recovery option.
Area of Science:
- Neurology
- Neuroscience
- Pharmacology
Background:
- Cognitive decline is a common consequence of stroke, increasing dementia risk.
- Vascular factors significantly contribute to cognitive impairment and dementia post-stroke.
- Few pharmacological interventions target post-stroke cognitive impairment.
Purpose of the Study:
- To evaluate the efficacy of citicoline in preventing cognitive decline after ischemic stroke.
- To assess citicoline's impact on specific cognitive domains in stroke survivors.
- To explore citicoline's potential as a treatment for vascular cognitive impairment and dementia.
Main Methods:
- A 6-month clinical trial involving patients with first-ever ischemic stroke.
- Assessment of cognitive functions including temporal orientation, attention, and executive function.
- Evaluation of citicoline's neuroprotective and neural repair mechanisms.
Main Results:
- Citicoline administration prevented cognitive decline in patients after ischemic stroke.
- Significant improvements were observed in temporal orientation, attention, and executive function.
- Citicoline demonstrated neuroprotective effects and enhanced neural repair in experimental models.
Conclusions:
- Citicoline is a safe and promising agent for improving stroke recovery.
- It may be beneficial for patients with vascular cognitive impairment and vascular dementia.
- Citicoline could be indicated for Alzheimer's disease patients with cerebrovascular disease.
Abstract:
Cognitive decline after stroke is more common than stroke recurrence. Stroke doubles the risk of dementia and is a major contributor to vascular cognitive impairment and vascular dementia. Neuropathological studies in most cases of dementia in the elderly reveal a large load of vascular ischemic brain lesions mixed with a lesser contribution of neurodegenerative lesions of Alzheimer disease. Nonetheless, few pharmacological studies have addressed vascular cognitive impairment and vascular dementia after stroke. Citicoline has demonstrated neuroprotective effects in acute stroke and has been shown to improve cognition in patients with chronic cerebrovascular disease and in some patients with Alzheimer disease. A recent trial lasting 6 months in patients with first-ever ischemic stroke showed that citicoline prevented cognitive decline after stroke with significant improvement of temporal orientation, attention, and executive function. Experimentally, citicoline exhibits neuroprotective effects and enhances neural repair. Citicoline appears to be a safe and promising alternative to improve stroke recovery and could be indicated in patients with vascular cognitive impairment, vascular dementia, and Alzheimer disease with significant cerebrovascular disease.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Dementia l: Introduction
Ischemic Stroke l: Introduction
Alzheimer's Disease: Treatment
Ischemic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
